Clinical Trial Update: Rituximab and Lenalidomide vs Rituximab Alone as Maintenance After R-chemoterapy for Relapsed/Refractory FL Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Rituximab plus Lenalidomide maintenance versus Rituximab alone maintenance after Rituximab-based therapy in relapsed/refractory follicul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)
• Rituximab (rituximab)

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Lymphoma, Follicular | Phase 3 | Status: ACTIVE_NOT_RECRUITING